Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Clearpoint Neuro Inc CLPT

Technology Scientific & Technical Instruments
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CLPT)

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

ACCESS Newswire February 26, 2025

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

ACCESS Newswire February 14, 2025

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

ACCESS Newswire February 12, 2025

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ACCESS Newswire January 27, 2025

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

ACCESS Newswire November 13, 2024

ClearPoint Neuro Reports Third Quarter 2024 Results

ACCESS Newswire November 7, 2024

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

ACCESS Newswire October 31, 2024

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

GlobeNewswire October 17, 2024

ClearPoint Neuro Announces Early Repayment of $10 Million Note

GlobeNewswire August 26, 2024
View More News ››

Opinion & Analysis (NDAQ:CLPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CLPT)

ClearPoint Neuro, Inc.: Pioneering Precision Navigation and

Looks like CLPT is making serious moves in the neuro space. 49% rev growth in neurosurgery segment and 27% in biologics is impressive...
MikeTester - January 23, 2025

Huge news for Clearpoint Neuro

https://www.digitaljournal.com/pr/news/accesswire/clearpoint-neuro-announces-fda-de-1915565459.html
SushiGobbler - November 14, 2024

Biotech

Is it time to take a chance on this one? Q3 was very good and I suspect Q4 will also shine. Down last while after great recovery. Maybe...
tiker22 - November 27, 2023

first

huh really, no one here yet 
meeTmyLo - March 16, 2021
View more Bullboard ››

Hypha Labs Inc.

Hypha Labs Inc.

Hypha Labs, Inc.is engaged in the research, development and commercialization of a revolutionary mushroom accelerator, the ...
View More »